Results 231 to 240 of about 74,894 (279)

Clinical and disease characteristics from REVEAL at time of enrollment (baseline): Prospective observational study of patients with polycythemia vera in the United States [PDF]

open access: yes, 2018
Boccia, Ralph V   +7 more
core   +1 more source

When Blood Disorders Meet Cancer: Uncovering the Oncogenic Landscape of Sickle Cell Disease. [PDF]

open access: yesJ Clin Med
Casadessus E   +5 more
europepmc   +1 more source

Potential application of XC3 (X = B, N) nanosheets in drug delivery of hydroxyurea anticancer drug: a comparative DFT study

Molecular Physics, 2021
The assessment of drug delivery performance of fabricated pristine XC3 monolayers (X = B, N) for the hydroxyurea anticancer drug was performed using periodic DFT calculations.
Rezvan Rahimi   +2 more
semanticscholar   +1 more source

Hydroxyurea

Archives of Dermatology, 1970
In a double-blind study, nine of ten cases of severe psoriasis demonstrated clinical and histopathologic response to hydroxyurea. No toxic reactions were noted. The drug may be less toxic than methotrexate and is efficacious in the management of psoriasis.
Robert B. Livingston, Stephen K. Carter
openaire   +2 more sources

Home - About - Disclaimer - Privacy